These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27184217)

  • 1. Depoliticising the political: Market solutions and the retreat of Swedish institutional drug treatment from state management.
    Edman J
    Int J Drug Policy; 2016 Jun; 32():93-9. PubMed ID: 27184217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An all-embracing problem description. The Swedish drug issue as a political catalyst 1982-2000.
    Edman J
    Int J Drug Policy; 2013 Nov; 24(6):558-65. PubMed ID: 23790617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital side hustles: Funding conundrums and perverse incentives in Tanzania's publicly-funded health sector.
    Marten MG; Sullivan N
    Soc Sci Med; 2020 Jan; 244():112662. PubMed ID: 31726268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ambiguous monolith - the Swedish drug issue as a political battleground 1965-1981.
    Edman J
    Int J Drug Policy; 2013 Sep; 24(5):464-70. PubMed ID: 23453300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoliberal reforms in Swedish primary health care: for whom and for what purpose?
    Dahlgren G
    Int J Health Serv; 2008; 38(4):697-715. PubMed ID: 19069288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug consumption rooms and the role of politics and governance in policy processes.
    Houborg E; Frank VA
    Int J Drug Policy; 2014 Sep; 25(5):972-7. PubMed ID: 24572642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms behind privatization: a case study of private growth in Swedish elderly care.
    Stolt R; Winblad U
    Soc Sci Med; 2009 Mar; 68(5):903-11. PubMed ID: 19136187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug use and the constitution of homo politicus in Swedish politics 1966-1979.
    Roumeliotis F
    Int J Drug Policy; 2024 Apr; 126():104357. PubMed ID: 38394951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving beyond access: towards a quality-orientated substance abuse treatment system in South Africa.
    Myers B; Petersen Z; Kader R; Parry CD
    S Afr Med J; 2012 Jun; 102(8):667-8. PubMed ID: 22831942
    [No Abstract]   [Full Text] [Related]  

  • 10. Market reforms in Swedish health care: a threat to or salvation for the universalistic welfare state?
    Diderichsen F
    Int J Health Serv; 1993; 23(1):185-8. PubMed ID: 8425787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financing and payment reform for primary health care and substance abuse treatment.
    Kunnes R; Niven R; Gustafson T; Brooks N; Levin SM; Edmunds M; Trumble JG; Coye MJ
    J Addict Dis; 1993; 12(2):23-42. PubMed ID: 8386551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting against COVID-19: With or without politics?
    Kovanic M; Steuer M
    Soc Sci Med; 2023 Nov; 337():116297. PubMed ID: 37832315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural patterns in Swedish health policy: a 30-year perspective.
    Saltman RB
    Health Econ Policy Law; 2015 Apr; 10(2):195-215. PubMed ID: 25079916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance abuse treatment services: an introduction.
    Lowman C
    J Ment Health Adm; 1992; 19(1):1-4. PubMed ID: 10171033
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there new public health management (NPM) in Nepal? Arguments for and against NPM in Nepal.
    Paudel M
    Soc Work Public Health; 2013; 28(7):702-12. PubMed ID: 24074134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of case management in the publicly funded substance abuse treatment system. The perspective of program directors, case managers and clients.
    Shwartz M; Stone DA; Camp J; Mulvey KP; Kane M; Plough A
    Care Manag J; 2000; 2(3):139-47. PubMed ID: 11398569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future funding for mental health and substance abuse: increasing burdens for the public sector.
    Levit KR; Kassed CA; Coffey RM; Mark TL; Stranges EM; Buck JA; Vandivort-Warren R
    Health Aff (Millwood); 2008; 27(6):w513-22. PubMed ID: 18840617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State-society nexus in Brazil and Venezuela and its effect on participatory governance efforts in health and other sectors.
    Mahmood Q; Muntaner C
    Int J Equity Health; 2020 Oct; 19(1):173. PubMed ID: 33100221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reregulation of the Swedish pharmacy sector-A qualitative content analysis of the political rationale.
    Wisell K; Winblad U; Sporrong SK
    Health Policy; 2015 May; 119(5):648-53. PubMed ID: 25841749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.